Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Groll

Showing results (141-150 of 205) with videos related to

Pageof 21
Sort By:
Journal of the American Chemical Society|August 18, 2022
Peroxy Intermediate Drives Carbon Bond Activation in the Dioxygenase AsqJDirk Auman, Felix Ecker, Sophie L Mader, et al.
Journal of Medicinal Chemistry|April 4, 2013
Potent proteasome inhibitors derived from the unnatural cis-cyclopropane isomer of Belactosin A: synthesis, biological activity, and mode of actionShuhei Kawamura, Yuka Unno, Anja List, et al.
Nature Communications|September 6, 2012
Discovery of acetylene hydratase activity of the iron-sulphur protein IspHIngrid Span, Ke Wang, Weixue Wang, et al.
Nature Communications|May 6, 2018
Structure and mechanism of the two-component α-helical pore-forming toxin YaxABBastian Bräuning, Eva Bertosin, Florian Praetorius, et al.
Journal of Medicinal Chemistry|January 8, 2026
Structure-Based Design of Pan-Selective Peptide Epoxyketones for the Three Human Immunoproteasome Active SitesPatrick M Dekker, Eva M Huber, Elmer Maurits, et al.
Angewandte Chemie (International Ed. in English)|September 23, 2014
Selective inhibition of the immunoproteasome by ligand-induced crosslinking of the active siteChristian Dubiella, Haissi Cui, Malte Gersch, et al.
European Journal of Medicinal Chemistry|August 31, 2018
Design, synthesis, and evaluation of cystargolide-based β-lactones as potent proteasome inhibitorsDoleshwar Niroula, Liam P Hallada, Camille Le Chapelain, et al.
Angewandte Chemie (International Ed. in English)|March 5, 2014
Harnessing the evolvability of tricyclic microviridins to dissect protease-inhibitor interactionsAnnika R Weiz, Keishi Ishida, Felix Quitterer, et al.
Nature|April 11, 2008
A plant pathogen virulence factor inhibits the eukaryotic proteasome by a novel mechanismMichael Groll, Barbara Schellenberg, André S Bachmann, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 25, 2014
Receptor-bound conformation of cilengitide better represented by its solution-state structure than the solid-state structureUdaya Kiran Marelli, Andreas O Frank, Bernhard Wahl, et al.
Pageof 21

Showing results (141-150 of 205) with videos related to

Sort By:
Pageof 21
Journal of the American Chemical Society|August 18, 2022
Peroxy Intermediate Drives Carbon Bond Activation in the Dioxygenase AsqJDirk Auman, Felix Ecker, Sophie L Mader, et al.
Journal of Medicinal Chemistry|April 4, 2013
Potent proteasome inhibitors derived from the unnatural cis-cyclopropane isomer of Belactosin A: synthesis, biological activity, and mode of actionShuhei Kawamura, Yuka Unno, Anja List, et al.
Nature Communications|September 6, 2012
Discovery of acetylene hydratase activity of the iron-sulphur protein IspHIngrid Span, Ke Wang, Weixue Wang, et al.
Nature Communications|May 6, 2018
Structure and mechanism of the two-component α-helical pore-forming toxin YaxABBastian Bräuning, Eva Bertosin, Florian Praetorius, et al.
Journal of Medicinal Chemistry|January 8, 2026
Structure-Based Design of Pan-Selective Peptide Epoxyketones for the Three Human Immunoproteasome Active SitesPatrick M Dekker, Eva M Huber, Elmer Maurits, et al.
Angewandte Chemie (International Ed. in English)|September 23, 2014
Selective inhibition of the immunoproteasome by ligand-induced crosslinking of the active siteChristian Dubiella, Haissi Cui, Malte Gersch, et al.
European Journal of Medicinal Chemistry|August 31, 2018
Design, synthesis, and evaluation of cystargolide-based β-lactones as potent proteasome inhibitorsDoleshwar Niroula, Liam P Hallada, Camille Le Chapelain, et al.
Angewandte Chemie (International Ed. in English)|March 5, 2014
Harnessing the evolvability of tricyclic microviridins to dissect protease-inhibitor interactionsAnnika R Weiz, Keishi Ishida, Felix Quitterer, et al.
Nature|April 11, 2008
A plant pathogen virulence factor inhibits the eukaryotic proteasome by a novel mechanismMichael Groll, Barbara Schellenberg, André S Bachmann, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 25, 2014
Receptor-bound conformation of cilengitide better represented by its solution-state structure than the solid-state structureUdaya Kiran Marelli, Andreas O Frank, Bernhard Wahl, et al.
Pageof 21